BRIEF published on 02/12/2026 at 18:05, 8 months 27 days ago THX Pharma and Biocodex conclude a major strategic agreement Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex
BRIEF published on 02/12/2026 at 18:05, 8 months 27 days ago THX Pharma Announces Webinar on Strategic Agreement with Biocodex Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 8 months 27 days ago THX Pharma et Biocodex concluent un accord stratégique majeur Webinaire Accord Stratégique THX Pharma Médicaments Neurologiques Biocodex
BRIEF published on 02/12/2026 at 18:05, 8 months 27 days ago THX Pharma annonce un webinaire sur son accord stratégique avec Biocodex Webinaire Accord Stratégique Batten-1 THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 8 months 27 days ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 8 months 27 days ago THX Pharma organise un webinaire pour commenter son accord stratégique avec Biocodex THX Pharma annonce un webinaire pour discuter de son accord avec Biocodex portant sur le développement de traitements pour les maladies neurologiques rares Webinaire Accord Stratégique Maladies Neurologiques Rares THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 9 months 1 day ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 9 months 1 day ago Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF published on 02/10/2026 at 18:05, 9 months 1 day ago Accord de licence stratégique pour les traitements des maladies rares Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 9 months 1 day ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
Published on 11/11/2026 at 23:30, 17 minutes ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 42 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 47 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 1 hour 17 minutes ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/11/2026 at 19:31, 4 hours 16 minutes ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 19:29, 4 hours 18 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 5 hours 5 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 18:00, 1 day 5 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 6 hours ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 1 day 6 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 6 hours ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
